| Literature DB >> 30064470 |
Hui-Yu Wang1, Shao-Qiang Wu1, Li Jiang1, Rong-Hai Xiao1, Ting Li1, Lin Mei1, Ji-Zhou Lv1, Jia-Jia Liu1, Xiang-Mei Lin2, Xue-Qing Han3.
Abstract
BACKGROUND: Insect-borne diseases could induce severe symptoms in human and clinical signs in animals, such as febrility, erythra, arthralgia and hemorrhagic fever, and cause significant economic losses and pose public health threat all over the world. The significant advantages of Luminex xMAP technology are high-throughput, high parallel and automation. This study aimed to establish a liquid bead array based on Luminex xMAP technology that was able to simultaneously detect multiple insect-borne pathogens.Entities:
Keywords: Insect-borne pathogens; Liquid array; Multiplex; Optimization
Mesh:
Substances:
Year: 2018 PMID: 30064470 PMCID: PMC6069843 DOI: 10.1186/s13071-018-2996-0
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Primer and probe sequences for the 10 kinds of pathogen
| Pathogen | Primer or probe sequence | Amplified fragment length (bp) | GenBank ID |
|---|---|---|---|
| ASFV | Forward primer: 5'-AGTTATGGGAAACCCGACCC-3' | 254 | FN557520 |
| Reverse primer: Biotin-5'-CCCTGAATCGGAGCATCCT-3' | |||
| Capture probe: NH2-C12-5'-AGCCTTATGTTCCAGTAGGGTTTG-3' | |||
| RC-probe: Biotin-5'-CAAACCCTACTGGAACATAAGGCT-3' | |||
| BTV | Forward primer: 5'-GCAGCATTTTGAGAGAGCGA-3' | 101 | KP 822059.1 |
| Reverse primer: Biotin-5'-CCCGATCATACATTGCTTCCT-3' | |||
| Capture probe: NH2-C12-5'-GGAGGAGCCGGCGAAAGCATA-3' | |||
| RC-probe: Biotin-5'-TATGCTTTCGCCGGCTCCTCC-3' | |||
| BB | Forward primer: 5'-AAGAGCAGACGGAACCAGAC-3' | 345 | AY502600 |
| Reverse primer: Biotin-5'-GTGCCATTTGAGTCGTATTG-3' | |||
| Capture probe: NH2-C12-5'-AATTCAGGCACTTCAACTTTAACAA-3' | |||
| RC-probe: Biotin-5'-TTGTTAAAGTTGAAGTGCCTGAATT-3' | |||
| EHDV | Forward primer: 5'-TGATTATGATGTTCATGGCGAA-3' | 189 | KU140939.1 |
| Reverse primer: Biotin-5'-ACCTTGGAGCTTCACTCTATCT-3' | |||
| Capture probe: NH2-C12-5'-TAGATGGATTTGACATACCGCCGGA-3' | |||
| RC-probe: Biotin-5'-TCCGGCGGTATGTCAAATCCATCTA-3' | |||
| VSV | Forward primer: 5'-TGGACGGGCTTGAAAATCAGTGCAAA-3' | 199 | KP 202364.1 |
| Reverse primer: Biotin-5'-TTGAATCTGGAAACAATAGTTCCGTATCT-3' | |||
| Capture probe: NH2-C12-5'-ATGTTCTTCCACATGTTCAAAAA-3' | |||
| RC-probe: Biotin-5'-TTTTTGAACATGTGGAAGAACAT-3' | |||
| WNV | Forward primer: 5'-GAGCCACTCAGGCAGGGAGATTCAG-3' | 496 | KY229074.1 |
| Reverse primer: Biotin-5'-AACACCACAGTGCCGTGACCT-3' | |||
| Capture probe: NH2-C12-5'-TGAAGGGAACAACCTATGGCGTCTG-3' | |||
| RC-probe: Biotin-5'-CAGACGCCATAGGTTGTTCCCTTCA-3' | |||
| CB | Forward primer: 5'-TGAGATTCGGGGGTTGTTGC-3' | 376 | M80806 |
| Reverse primer: Biotin-5'-ACACCTCCTTATTCCCACTCG-3' | |||
| Capture probe: NH2-C12-5'-TTTAACGGCGCTCTCGGTTTATGCG-3' | |||
| RC-probe: Biotin-5'-CGCATAAACCGAGAGCGCCGTTAAA-3' | |||
| RVFV | Forward primer: 5'-ATGATGACATTAGAAGGGA-3' | 298 | DQ380149 |
| Reverse primer: Biotin-5'-ATGCTGGGAAGTGATGAG-3' | |||
| Capture probe: NH2-C12-5'-ATGCTGTAGTTCCAAACTCAGCCCT-3' | |||
| RC-probe: Biotin-5'-AGGGCTGAGTTTGGAACTACAGCAT-3' | |||
| EBV | Forward primer: 5'-CGCTGGCTGGTGTTAATGTAGGG-3' | 249 | KC545392.1 |
| Reverse primer: Biotin-5'-ATGCAGTCGTGATGGCTTCGG-3' | |||
| Capture probe: NH2-C12-5'-CAGCAAACTAACGCAATGGTAACCT-3' | |||
| RC-probe: Biotin-5'-AGGTTACCATTGCGTTAGTTTGCTG-3' | |||
| SBV | Forward primer: 5'-GAAGCTAGTGCTCAGATTGTCATGC-3' | 130 | KC545392.1 |
| Reverse primer: Biotin-5'-GTGGATAGAAGTCAAAAGCATCAAGG-3' | |||
| Capture probe: NH2-C12-5'-AAGGGATGCACCTGGGCCGATGGTTA-3' | |||
| RC-probe: Biotin-5'-TAACCATCGGCCCAGGTGCATCCCTT-3' |
Abbreviations: ASFV African swine fever virus, BTV bluetongue virus, BB Borrelia burgdorferi, EHDV epizootic hemorrhagic disease virus, VSV vesicular stomatitis virus, WNV West Nile virus, CB Coxiella burnetii, RVFV Rift Valley fever virus, EBV Ebola virus, SBV Schmallenberg virus
Information on the nucleic acid samples used for clinical sample detection
| Sampling area | Sample category | Sample number | Month |
|---|---|---|---|
| Inner Mongolia Autonomous Region | Mosquitoes | 350 | June-July |
| Ticks | 200 | April-June | |
| Midges | 230 | June-July | |
| Xinjiang Uighur Autonomous Region | Ticks | 270 | April-June |
| Mosquitoes | 300 | June-July | |
| Yunnan Province | Mosquitoes | 320 | May-August |
| Midges | 200 | June-September | |
| Heilongjiang Province | Mosquitoes | 290 | June-August |
| Ticks | 100 | April-June | |
| Midges | 220 | June-July | |
| Guangdong Province | Mosquitoes | 300 | March-June |
| Midges | 220 | May-September | |
| Total | 3000 |
Analysis of positive samples using the optimized liquid array detection system and corresponding reference methods or nucleic acid detection kits
| Pathogens | Results of the two methods | Description of reference method or nucleic acid detection kit | |
|---|---|---|---|
| Optimized liquid array detection system | Reference methods or nucleic acid detection kit | ||
| ASFV | 0 | 0 | PCR and agarose gel electrophoresis (primers recommended by OIE) |
| BTV | 53 | 53 | BTV nucleic acid detection kita |
| BB | 16 | 16 | |
| EHDV | 0 | 0 | Virus isolation |
| VSV | 0 | 0 | VSV RT-PCR detection kitc |
| WNV | 0 | 0 | WNFV real-time PCR detection kitd |
| CB | 17 | 17 | Isolation of pathogen |
| RVFV | 0 | 0 | RVFV nucleic acid detection kite |
| EBV | 0 | 0 | EBV nucleic acid detection kitf |
| SBV | 0 | 0 | Virotype SBV real-time RT-PCR kit(FLI-B585)g |
aBTV nucleic acid detection kits and the real-time fluorescence quantitative PCR method were purchased from Beijing Senkang Biotechnology Development Co., Ltd., Beijing, China
bBorrelia burgdorferi nucleic acid detection kits and the PCR-fluorescent probe method were purchased from Guangzhou Vipotion Biotechnology Co. Ltd., Guangzhou, China
cVSV RT-PCR detection kits were purchased from YUABIO Biotechnology Co., Beijing, China
dWNFV real-time PCR detection kits were purchased from Beijing Biolab Technology Co. Ltd.
eRVFV nucleic acid detection kits and the real-time fluorescence quantitative PCR method were purchased from Beijing Senkang Biotechnology Development Co., Ltd., Beijing, China
fEBV nucleic acid detection kits and the PCR-fluorescent probe method were purchased from DA AN GENE Co. Ltd., Guangzhou, China
gVirotype SBV real-time RT-PCR kit (FLI-B585) was purchased from Qiagen, Valencia, CA, USA
Fig. 1Median fluorescent intensity (MFI) for the 10 insect-borne pathogens with different ratios of forward/reverse primers, quantities of PCR product, melting temperatures for the hybridization and hybridization durations. a MFIs for different ratios of forward/reverse primers. b MFIs for different quantities of PCR product. c MFIs for different melting temperatures for the hybridization. d MFIs for different hybridization durations
Fig. 2Calibration curves for each pathogen. A 10-fold dilution of pathogens was added to the system to create correlative mathematical curves with MFI values. All of the resulting correlation coefficients (R2) were greater than 0.95, indicating good relationships between the concentration of the target and fluorescence
Fig. 3Median fluorescent intensity (MFI) for the 10 insect-borne pathogens. PCR product was replaced with 1 μl of double-distilled H2O for the blank control group and 1 μl of negative PCR product for the negative control group. The error bars indicate the standard deviations. Abbreviations: M, mixed nucleic acid of the 10 pathogens; NC, negative control; Blank, blank control
Fig. 4Specificity (a) and sensitivity (b) of the liquid array detection system. PCR product in the blank control group was replaced with 1 μl of double-distilled H2O in the blank control group, and 1 μl negative PCR product in the negative control group. Insect-borne pathogens including dengue virus (DENV), tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV), Xinjiang hemorrhagic fever virus (XHFV), spotted fever group rickettsiae (SFGR), and ehrlichiae and chikungunya virus (CHIKV) were used as controls. Abbreviations: NC, negative control; Blank, blank control
Results of triplicate experiments to test the reproducibility of the liquid array detection system
| Insect-borne virus | MFI | SD | CV (%) | ||
|---|---|---|---|---|---|
| Duplication 1 | Duplication 2 | Duplication 3 | |||
| WNV | 4198.00 | 4054.00 | 4126.00 | 72.00 | 1.75 |
| BB | 4293.00 | 4593.50 | 4302.00 | 170.95 | 3.89 |
| ASFV | 1879.00 | 2019.50 | 1952.00 | 70.27 | 3.60 |
| VSV | 2974.50 | 3153.50 | 3012.00 | 94.40 | 3.09 |
| BTV | 8792.00 | 8811.00 | 8800.00 | 9.54 | 0.10 |
| EHDV | 3871.00 | 3671.50 | 3796.00 | 100.77 | 2.67 |
| CB | 1995.00 | 1950.50 | 1960.30 | 23.38 | 1.19 |
| EBV | 7598.50 | 8062.00 | 7693.00 | 244.92 | 3.15 |
| RVFV | 3800.50 | 4426.00 | 3912.00 | 333.64 | 8.24 |
| SBV | 8142.00 | 8307.00 | 8423.00 | 141.21 | 1.70 |
Abbreviations: ASFV African swine fever virus, BTV bluetongue virus, BB Borrelia burgdorferi, EHDV epizootic hemorrhagic disease virus, VSV vesicular stomatitis virus, WNV West Nile virus, CB Coxiella burnetii, RVFV Rift Valley fever virus; EBV Ebola virus, SBV Schmallenberg virus, MFI median fluorescent intensity, SD standard deviation, CV coefficient of variation